Circulating Troponin As Measured by a Sensitive Assay for Cardiovascular Risk Assessment in Primary Prevention | Zendy

David M. Leistner | Zendy; Jens Klotsche | Zendy; Lars Pieper | Zendy; Günter K. Stalla | Zendy; Hendrik Lehnert | Zendy; Sigmund Silber | Zendy; Winfried März | Zendy; HansUlrich Wïttchen | Zendy; Andreas M. Zeiher | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Circulating Troponin As Measured by a Sensitive Assay for Cardiovascular Risk Assessment in Primary Prevention

Author(s) -

David M. Leistner,

Jens Klotsche,

Lars Pieper,

Günter K. Stalla,

Hendrik Lehnert,

Sigmund Silber,

Winfried März,

HansUlrich Wïttchen,

Andreas M. Zeiher

Publication year - 2011

Publication title -

clinical chemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.705

H-Index - 218

eISSN - 1530-8561

pISSN - 0009-9147

DOI - 10.1373/clinchem.2011.174292

Subject(s) - mace , medicine , troponin i , troponin , cardiology , natriuretic peptide , prospective cohort study , population , cohort , risk factor , cohort study , biomarker , coronary artery disease , risk assessment , troponin t , myocardial infarction , heart failure , environmental health , percutaneous coronary intervention , biochemistry , chemistry , computer security , computer science

Measuring circulating cardiac troponin using novel sensitive assays has revealed that even minute elevations are associated with increased mortality in patients with coronary artery disease or even in the general population. Less well defined, however, is the incremental value of measuring circulating cardiac troponin I (cTnI) by a sensitive assay for risk assessment in primary prevention.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research